- Home
- INKT vs RENB Comparison
INKT vs RENB Comparison
Compare INKT & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- RENB
- Stock Information
- Founded
- INKT 2017
- RENB 2011
- Country
- INKT United States
- RENB United States
- Employees
- INKT N/A
- RENB N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- INKT Health Care
- RENB Health Care
- Exchange
- INKT Nasdaq
- RENB Nasdaq
- Market Cap
- INKT 48.7M
- RENB 57.7M
- IPO Year
- INKT 2021
- RENB N/A
- Fundamental
- Price
- INKT $15.83
- RENB $0.19
- Analyst Decision
- INKT Buy
- RENB
- Analyst Count
- INKT 3
- RENB 0
- Target Price
- INKT $37.50
- RENB N/A
- AVG Volume (30 Days)
- INKT 87.6K
- RENB 741.6K
- Earning Date
- INKT 08-14-2025
- RENB 10-09-2025
- Dividend Yield
- INKT N/A
- RENB N/A
- EPS Growth
- INKT N/A
- RENB N/A
- EPS
- INKT N/A
- RENB N/A
- Revenue
- INKT N/A
- RENB N/A
- Revenue This Year
- INKT N/A
- RENB N/A
- Revenue Next Year
- INKT N/A
- RENB N/A
- P/E Ratio
- INKT N/A
- RENB N/A
- Revenue Growth
- INKT N/A
- RENB N/A
- 52 Week Low
- INKT $4.56
- RENB $0.18
- 52 Week High
- INKT $76.00
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- INKT 53.11
- RENB 30.06
- Support Level
- INKT $13.11
- RENB $0.20
- Resistance Level
- INKT $15.26
- RENB $0.26
- Average True Range (ATR)
- INKT 1.23
- RENB 0.02
- MACD
- INKT 0.08
- RENB -0.00
- Stochastic Oscillator
- INKT 85.26
- RENB 7.01
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.